How do rebates and negotiated discounts influence formulary design and pharmaceutical pricing?

• A. They do not affect formulary design
• B. They affect the net price of drugs, influencing formulary placement, tiering, and member cost-sharing strategies
• C. They require mandatory co-pays for all drugs
• D. They only influence marketing budgets

Answer: (B)

Rebates and negotiated discounts shift the economics of medications from the listed price to the net price paid by the plan. Because these incentives reduce the net cost, formulary designers use them to decide which drugs get placed on preferred tiers and what member cost-sharing looks like. A drug with favorable net pricing through a rebate is more likely to be favored on the formulary, often with lower copays or coinsurance, while drugs with less favorable net pricing may be placed on non-preferred tiers or excluded. These arrangements can also be tied to volume or outcomes, further guiding selection and pricing. In short, rebates and negotiated discounts shape both what is covered and at what price the patient pays, not just marketing budgets or universal co-pays.